COAGULOPATHY
Clinical trials for COAGULOPATHY explained in plain language.
Never miss a new study
Get alerted when new COAGULOPATHY trials appear
Sign up with your email to follow new studies for COAGULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Whole blood may be just as good as standard transfusions for trauma patients
Disease control CompletedThis study looked at whether giving whole blood (all blood parts together) is as effective as giving separate blood products (red cells, plasma, platelets) to trauma patients with severe bleeding and blood clotting problems. About 200 adults with major injuries were included. The…
Matched conditions: COAGULOPATHY
Phase: PHASE3 • Sponsor: Direction Centrale du Service de Santé des Armées • Aim: Disease control
Last updated May 03, 2026 09:04 UTC
-
Can a plasma product fix clotting in septic shock? new study investigates
Disease control CompletedThis study looked at whether a special plasma product called OctaplasLG can help treat blood clotting problems in people with septic shock. The researchers wanted to see if giving this plasma early could improve outcomes. The study involved 60 adults with septic shock and clottin…
Matched conditions: COAGULOPATHY
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated May 03, 2026 08:55 UTC
-
Battlefield plasma may speed up trauma care in civilians
Disease control CompletedThis study tested whether a freeze-dried plasma that can be prepared in 6 minutes helps control bleeding in trauma patients better than standard frozen plasma, which takes longer to thaw. The trial included 42 adults with severe bleeding from injury who needed blood transfusions.…
Matched conditions: COAGULOPATHY
Phase: PHASE3 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
New Spray-Dried plasma passes early safety check in healthy volunteers
Knowledge-focused CompletedThis early-stage study tested the safety of a new spray-dried blood plasma product called FrontlineODP in 24 healthy adults. Participants received one, two, or four units of the product, and researchers monitored for side effects and changes in blood clotting. The goal was to see…
Matched conditions: COAGULOPATHY
Phase: PHASE1 • Sponsor: Velico Medical • Aim: Knowledge-focused
Last updated May 03, 2026 09:05 UTC
-
Scientists watch sepsis blood vessels in real time
Knowledge-focused CompletedThis study looked at 30 adults with sepsis to understand how tiny blood vessels under the tongue change and how these changes relate to blood clotting problems. Researchers measured blood vessel density and other markers without giving any treatment. The goal was to learn more ab…
Matched conditions: COAGULOPATHY
Sponsor: Università Politecnica delle Marche • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:03 UTC